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Abstract
Background: Decidualization, the differentiation process of maternal uterine stromal cells into secretory decidual
cells, is a prerequisite for successful implantation and progression of pregnancy. For in vitro differentiation mostly
primary human endometrial stromal cells (HESC) isolated from uterine samples after hysterectomy for benign
gynaecological diseases are utilised. However, a continuous supply of endometrial tissue is often lacking. Hence,
we analysed whether cultivated human decidual stromal cells (HDSC) prepared from first trimester pregnancy
terminations may represent an alternative model system for in vitro decidualization. Moreover, based on the
expression of critical marker genes these cells were compared to a previously established endometrial stromal cell
line during in vitro differentiation.
Methods: HDSC isolated from decidual tissue attached to first trimester placentae, and telomerase-transformed
human endometrial stromal cells (THESC) were characterised by immunofluorescence and differentiated in vitro
using either cyclic adenosine monophosphate (cAMP) and/or estrogen (E2)/progesterone (P4). Proliferation was
measured by analyzing cumulative cell numbers. Expression of mRNAs encoding progesterone receptor (PR),
prolactin (PRL), insulin-like growth factor binding protein-1 (IGFBP1), and Dickkopf-1 (DKK1) was evaluated using
quantitative PCR after 3, 6, 9 and 12 days of in vitro differentiation. PRL and IGFBP-1 protein expression was
investigated by enzyme-linked immunosorbent assay (ELISA) and Western blotting, respectively. Furthermore,
forkhead box O1A (FOXO1A), a critical transcription factor in decidualization, was analysed by immunofluorescence
and Western blotting at two different time points of differentiation.
Results: Treatment with cAMP provoked morphological changes and growth arrest of THESC and HDSC, the latter
showing loss of cells after 6 days of treatment. E2P4 stimulation did neither affect cell morphology nor proliferation
of THESC and HDSC. Upon cAMP stimulation PR mRNA was suppressed in HDSC but not in THESC, whereas E2P4
did not alter transcript levels in both cell types. Protein expression of PR-A and PR-B was detectable in HDSC and
diminished under cAMP, whereas THESC failed to produce the nuclear receptors. Supplementation of cAMP
induced mRNA and protein expression of PRL and IGFBP-1 in both cell types at day 3, 6, 9, and 12 of treatment. In
HDSC stimulation with E2P4 increased PRL and IGFBP-1 mRNA and protein production, whereas hormone
treatment did not induce the two factors in THESC. E2P4 increased DKK1 mRNA at all time points in HDSC and
cAMP provoked induction at day 9 and 12 of differentiation. In contrast, cAMP suppressed DKK1 mRNA in THESC,
whereas E2P4 was ineffective. In both cell types combined treatments with cAMP and E2P4 provoked higher
expression levels of PRL and IGFBP1 mRNA and protein as compared to cAMP stimulation alone. FOXO1A protein
and its nuclear abundance were increased by cAMP in both cell types. However, reduction of its nuclear
localisation upon E2P4 treatment could only be observed in HDSC.
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Conclusion: Both HDSC and THESC may represent suitable model systems for cAMP-dependent in vitro
decidualization. Since cAMP decreases cell viability of HDSC after 6 days of incubation, this substance should be
preferentially used in short-term experiments. Progesterone treatment of THESC might not be applicable since
these cells lack progesterone response and PR protein. In contrast, stimulation of PR-expressing HDSC with E2P4 or
cAMP/E2P4 may represent an appropriate protocol for human in vitro decidualization inducing and maintaining
expression of critical marker genes in a time-dependent manner.
Background
Differentiation of estrogen-primed, uterine stromal cells
into stromal cells of pregnancy, termed decidualization,
starts in the secretory phase of the menstrual cycle due
to rising progesterone levels. In humans the process
occurs independently of an implanting blastocyst but is
only maintained upon pregnancy, since absence of a
conceptus provokes shedding of the decidualized endo-
metrial layer and menstruation. Decidualization involves
profound changes in cellular function, morphology and
gene expression. Typically, spindle-shaped uterine stro-
mal cells transform into polygonal, epithelial-like decid-
ual cells producing characteristic hormones, growth
factors and cytokines such as PRL [1], tissue factor [2],
IGFBP1 [3], interleukin (IL)-15 [4] or IL-11 [5]. Secreted
factors of the decidua are thought to fulfil numerous
functions in pregnancy such as regulation of placental
trophoblast implantation and invasion, recruitment and
differentiation of uterine natural killer (NK) cells and
protection against immune-mediated damage or oxida-
tive stress [6-8]. Moreover, decidual stromal cells
actively participate in remodelling of the extracellular
matrix of the uterus by expressing diverse extracellular
matrix (ECM)-proteins such as collagen IV, fibronectin,
laminin and alpha smooth-muscle actin, the latter pro-
voking myofibroblast-like properties of the cells [9,10].
The crucial role of decidual cells in pregnancy is further
emphasized by the fact that gene knock-out of different
decidual proteins in mice caused failures in implanta-
tion, infertility or intrauterine lethality [11].
Although the molecular mechanisms of decidualization
are still poorly understood, various critical factors con-
trolling differentiation and decidua-specific hormone
expression have been unravelled. Transcription factors
such as HoxA-10, HoxA-11, FOXO1A, Stat5 and C/
EBPb were shown to control promoter activity of decid-
ual PRL and/or IGFBP1 in a differentiation-dependent
manner [12]. Moreover, steroid hormones and their
nuclear receptors, estrogen receptor (ER) and PR, play a
pivotal role in decidual differentiation, since lack of these
genes impairs implantation and decidualization [8].
Accordingly, progesterone is thought to be necessary to
maintain the decidualized phenotype of the estrogen-
primed endometrium. However, progesterone alone is a
weak inducer of decidualization in primary HESC and
the combined action of progesterone and cAMP is
required for maximal and sustained expression of decid-
ual marker genes [12]. For example, the decidual prolac-
tin promoter lacking a palindromic PR recognition
sequence, can only be stimulated with progesterone
when cultures were pre-treated with exogenous cAMP
suggesting that activation of the proteinkinase A pathway
may enhance the transcriptional activity of PR through
modification of PR and its co-activators [13]. Critical
ligands such as relaxin, prostaglandin E2 or gonadotro-
phins are thought to activate cAMP-dependent signalling
in these cells [14]. On the other hand, progesterone treat-
ment provokes elevation of endogenous cAMP levels in
decidualizing stromal cells [15] suggesting complex
cross-talk between the two signalling pathways.
Given the fact that cAMP and steroid hormones are
critically involved in uterine stromal cell differentiation,
numerous protocols using exogenous cAMP analogues
and/or estrogen/progestational hormones, such as P4 or
medroxyprogesterone acetate (MPA) in vitro have been
developed [14]. As cellular model for human in vitro
decidualization HESC, which have been isolated from
uterine samples and biopsies after hysterectomy for
benign gynaecological conditions, such as myomas, or
patients undergoing tubal ligation, are widely utilised
[16,17]. However, availability of physiological, endome-
trial tissue might be limited provoking the need for
alternative sources and model systems. Indeed, different
cell lines have been developed which can be utilised for
cAMP-dependent differentiation but often lack P4
responsiveness [18,19]. Hence, we herein analysed stro-
mal cells which have been isolated from decidual tissue
of first trimester pregnancy terminations as a possible
model system of cAMP and/or E2P4-induced deciduali-
zation. Moreover, a commonly used, telomerase-trans-
formed cell line, THESC [20], was investigated in
parallel with respect to cAMP/steroid hormone-depen-
dent differentiation and expression of decidual marker
genes.
Methods
Isolation and cultivation of primary human decidual
stromal cells
Decidual specimen were obtained from legal abortions
of healthy first trimester pregnancies (between 8th and
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11th week of gestation, n = 13) with the permission of
the ethical committee of the Medical University of
Vienna. After separation of decidual tissues from the
placenta, samples were washed in phosphate buffered
saline to remove blood clots and subsequently minced
in 3 mm3 pieces in a small volume of Hank’s balanced
salt solution (HBSS, Sigma-Aldrich, St. Louis, MO). Tis-
sue fragments were collected in a T-75 cell culture flask
and covered with 50 ml digestion solution. Primary
human decidual stromal cells were prepared by enzy-
matic dispersion using 2 mg/ml collagenase I (484 IU/
ml, Invitrogen, Paisly, UK) and 0.5 mg/ml DNAse I
(Sigma-Aldrich) in HBSS containing 25 mM HEPES.
After digestion (60 minutes at 37°C) in a shaking water
bath, supernatant containing dispersed cells was filtered
through a 70 μm nylon mesh (BD Biosciences, Bedford,
UK) to remove larger tissue fragments. Residual undi-
gested tissue was further incubated for 60 minutes in 25
ml of digestion solution. Subsequently, supernatants
were pooled, centrifuged at 1000 rpm for 5 minutes and
pellets were washed twice in HBSS. Isolated cells were
seeded in phenolred-free DMEM/F12 medium (Invitro-
gen) supplemented with 10% heat-inactivated fetal
bovine serum (PAA Laboratories GmbH, PaschingAus-
tria), 1% ITS+ Premix (BD Biosciences), and 50 μg/ml
Gentamicin (Invitrogen) and cultivated at 37°C, 5% CO2
and 95% humidity. Purity of HDSC was routinely exam-
ined by immunofluorescence using antibodies against
vimentin and cytokeratin 7 detecting stromal, epithelial
and endothelial cells, respectively (see below). Cultures
were negative for CD31 (1 μg/ml; Abcam, Cambridge,
UK), HUVEC were used as a positive control.
Re-decidualization of primary human decidual stromal
cells
For in vitro decidualization isolated HDSC were utilized
between passage three and five. Briefly, cells were con-
fluently seeded in 24-well plates (2.5 × 105/cm2) and sti-
mulated on the next day with 0.5 mM 8-Bromo-cAMP
(Sigma-Aldrich) and/or 10 nM estrogen (E2; 17b-estra-
diol-acetate; Sigma-Aldrich)/1 μM progesterone (P4; 4-
pregnene-3,20-dione; Sigma-Aldrich) for 3, 6, 9 and 12
days. HDSC kept under the same culture conditions but
without addition of cAMP or E2P4 served as non-stimu-
lated controls. Every third day medium was changed and
stimuli were refreshed. Supernatants were collected,
immediately frozen in liquid nitrogen and stored at -80°
C for further analyses. Morphological changes were
daily monitored with a phase contrast microscope and
photographs were taken using a digital camera (C-4040
Zoom, Olympus, Vienna, Austria) for documentation. In
addition, total protein and RNA were extracted from
decidualizing cultures or non-stimulated controls at
indicated time points.
Cultivation and decidualization of THESC
The telomerase-immortalised endometrial stromal cell
line THESC [20] was purchased from American Type
Culture Collection (CRL-4003; Wesel, Germany) and
cultivated as described by the supplier. Briefly, cells
were cultured in phenol red-free DMEM/F12 medium
(Invitrogen) supplemented with 10% heat-inactivated
fetal bovine serum (PAA Laboratories GmbH), 1% ITS+
Premix (BD Biosciences) and puromycin (5 μg/μl; Invi-
trogen). In vitro decidualization of THESC was per-
formed as described above for HDSC.
Immunofluorescence of decidual tissue and cultured cells
First trimester decidual tissues (n = 3 between 8th and
10th week) were washed with phosphate buffered saline
(PBS) and fixed for at least 4 hours in 4% paraformalde-
hyde. After embedding serial sections (3 μm) were pre-
pared on a Microm HM 355S microtome and mounted
on silanized microscope slides. Subsequently, slides were
dried for 15 minutes at 55°C and dewaxed in xylol for
10 minutes. Finally sections were slowly rehydrated in
decreasing concentrations of ethanol (100%, 96% and
70%) and gathered in deionised water. Antigen retrieval
was performed using 0.05% citraconic anhydride solu-
tion pH 7.0 (Thermo Fisher Scientific, Waltham, MA) at
98°C for 20 minutes. Slides were allowed to cool down
for 30 minutes at room temperature before they were
washed three times with PBS and clamped with plastic
cover slips (Shandon, Frankfurt, Germany). Unspecific
binding sites were blocked with 100 μl 0.05% fish skin
gelatin from cold water fish (Sigma-Aldrich)/PBS for 30
minutes at room temperature and 100 μl primary anti-
bodies diluted in blocking solution were administered.
After overnight incubation at 4°C slides were washed
(100 mM TrisCl pH 7.5, 50 mM NaCl, 0.05% Tween20)
and covered with 100 μl secondary antibodies diluted in
blocking buffer. After one hour sections were washed
again and counterstained with 100 μl DAPI (Roche
Diagnostics GmbH, Vienna, Austria) diluted 1:1000 in
PBS for 10 minutes. After a final washing step, slides
were removed from the staining chamber and mounted
with Fluoromount-G (Southern Biotechnology, Birming-
ham, UK). Sections were dried overnight and subse-
quently analysed by fluorescence microscopy using a BX
50 Microscope (Olympus). For immunofluorescence of
HDSC and THESC, cells were seeded on 8-well cham-
ber slides, fixed with 4% paraformaldehyde for 10 min-
utes, washed, and permeabilized with 0.1% Triton-X 100
(Sigma-Aldrich) for 5 minutes. Blocking, incubation
with primary and secondary antibodies and counter-
staining with DAPI were done as described above. The
following primary and secondary antibodies were used:
mouse anti-human cytokeratin 7, OV-TL12/30, Dako,
1:100; rabbit anti-human vimentin, H-84, Santa Cruz
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Biotech. 1:100; rabbit anti-human FOXO1A, C29H4,
Cell Signaling Technology, Danvers, MA, 1:100; goat-
anti-mouse Alexa Fluor 488, goat-anti-rabbit Alexa
Fluor 568 or goat-anti-rabbit Alexa Fluor 488. All sec-
ondary antibodies were diluted 1:500. Analysis of signals
was carried out by fluorescence microscopy (Olympus
BX50) and digitally photographed. To determine
FOXO1A protein expression digital images (four differ-
ent fields for each condition) were counted using Cell^P
Soft Imaging System (Olympus). Subsequently the ratio
of FOXO1A-positive nuclei to DAPI-stained nuclei was
calculated.
Proliferation assay
To assess proliferation during decidualization cumula-
tive cell numbers were measured. Primary HDSC and
THESC were confluently seeded in duplicates (2.5 ×
105/cm2; 12-well plates), respectively. On the next day
cultures were stimulated with cAMP or E2P4. Subse-
quently, cultures were trypsinized after 3, 6, 9 and 12
additional days and cell numbers were counted using a
CASY Cell Counter (Schärfer System, Reutlingen,
Germany).
RNA extraction and quantitative real-time PCR
Total RNA was extracted by direct lysis in the culture
dishes using TriFast Reagent (PeqLab, Erlangen, D)
according to the manufacturer’s instructions. RNA
amount and integrity were evaluated using the Agilent
Bioanalyzer 2100 (Agilent, Palo Alto, CA). 2 μg RNA
were reverse transcribed using 200U of RevertAid H
Minus M.MuLV Reverse Transcriptase (Fermentas, St.
Leon-Rot, D), 0.2 μg Hexanucleotide Mix (Roche Diag-
nostics GmbH, Vienna, Austria), 0.5 μl RNaseOUT
(Recombinant Ribonuclease Inhibitor, Invitrogen) and
0.5 mM dNTP (Promega, Madison, WI) in final volume
of 20 μl. Quantitative real-time PCR was performed on
the ABI 5700 Sequence Detection System (Applied Bio-
systems, Carlsbad, CA) using Taq Man Gene Expression
Assays (TaqMan Universal PCR Master Mix, 20× Taq
Man Gene Expression Assay Mix form PRL (Hs
00168730_m1), IGFBP1 (Hs 00426285_m1), DKK1 (Hs
0018740_m1), PR (Hs01556707_m1) and TATA-box
binding protein (TBP; TaqMan endogenous control)
according to the manufacturer’s instructions. Calculation
of signals was done as suggested in the PE Biosystems
Sequence Detector User Bulletin and elsewhere [21].
Briefly, threshold cycle (Ct) is defined as the first fluores-
cent signal reaching statistical significance above back-
ground. For each individual condition, normalisation to
Ct values of the house keeping gene (TBP) was per-
formed (calculation of ΔCt values). Subsequently, relative
expression levels were evaluated by using transcript levels
of unstimulated controls of day 3 as calibrator (ΔΔCt).
Protein extraction and Western blot analyses
Isolation of total cellular protein was performed by
freezing (liquid nitrogen)-thawing in a buffer containing
50 mM Tris-HCl, 125 mM NaCl, 0,1% NP-40, 5 mM
EDTA, 50 mM NaF, 1 mM DTT, protease inhibitor
cocktail 1:100 and HALT Phosphatase Inhibitor Cocktail
1:100 (Pierce, Rockford, IL). Nuclear/cytoplasmic
extracts were prepared using NE-PER nuclear and cyto-
plasmic extraction reagent according to the manufac-
turer’s instructions (Pierce, Rockford, IL). For detection
of PR or FOXO1A protein expression equal amounts
(20 μg) of total or nuclear protein measured by Bradford
assay (Bio-Rad Laboratories, Hercules, CA) were sepa-
rated on 8.5% (PR) or 10% (FOXO1A) SDS/polyacryla-
mide gels. For analyses of IGFBP1 concentrations in
supernatants (1 ml aspirated from 12 wells) sample pre-
paration was performed under non-reducing conditions.
Volumes were normalised to the respective cell numbers
measured with Casy Cell Counter, adjusted to 20 μl with
culture medium and 20 μl of 2× Novex Tris-Glycine
Sample Buffer (Invitrogen, Carlsbad, CA) were added.
After incubation for 10 minutes at room temperature,
samples were loaded onto 12.5% SDS/polyacrylamide
gels. After separation proteins were transferred onto
methanol-activated polyvinyliden difluoride (PVDF)
membranes (Amersham, Buckinghamshire, UK) in a
buffer containing 25 mM Tris.Cl, pH 8.3, 0,5% SDS, 192
mM glycine, 20% methanol. Subsequently PVDF mem-
branes were blocked with 5% non-fat dry milk/Tris-buf-
fered Saline-Tween 20 (TBS-T) for 60 minutes at room
temperature to eliminate unspecific binding and incu-
bated overnight with primary antibodies in 0.5% non-fat
dry milk/TBS-T at 4°C as described [21]. The following
primary antibodies were used: mouse anti-human
IGFBP1 (1 μg/ml clone 33627; R&D Systems, Minnea-
polis, MN); rabbit anti-human PR (1:1000; Cell Signaling
Technology); rabbit anti-human FOXO1A (1:1000,
C29H4, Cell Signaling Technology). PVDF membranes
were washed three times for 5 minutes in 1× TBS-T
and subsequently treated with secondary anti-mouse or
anti-rabbit horseradish peroxidase-linked antibodies
(anti-mouse IgG, Sigma; anti-rabbit IgG, Amersham;
both diluted 1:50.000 in 0.5% non-fat dry milk/TBS-T).
After one hour of incubation at room temperature blots
were rinsed three times for 5 minutes and signals were
developed by using ECL Plus Western blotting detection
system according to the manufacturer’s instruction
(Amersham). Finally membranes were exposed to auto-
radiography for visualization of signals. Antibodies bind-
ing IGFBP1, FOXO1A, PR-A and PR-B detected specific
signals at 32 kD, 78 kD, 90 kD, and 118 kD, respec-
tively. For positive control of PR protein expression
total protein lysates of the breast cancer cell line T47D
were utilised. To monitor equal protein loading of
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cellular extracts, blots were again washed three times
with 1xTBS-T for 10 minutes, blocked in 5% non-fat
dry milk for 60 minutes and incubated with rabbit anti-
human GAPDH antibody (1:1000; Cell Signaling Tech-
nology) or mouse anti-human TopoIIb antibodies (0.25
mg/ml; BD Biosciences, normalization of nuclear protein
extracts) over night at 4°C. GAPDH (37 kD) was detect-
able both in cytoplasmic and nuclear fractions as
recently shown [22], whereas TopoIIb (180 kD) was
exclusively found in the nucleus.
Prolactin ELISA
Secreted PRL was measured in culture supernatants
using a PRL ELISA according to the manufacturer’s
instructions (Alpco, Salem, NH) and normalised to cell
numbers. Intra-assay precision levels indicated by the
coefficient to variation ranged between 2.1% and 4.6%
and inter-assay precision levels between 3.1% and 5.4%;
sensitivity was 2 ng/ml.
Statistical analysis
For comparison of two conditions of interest statistical
analyses were performed with Student’s paired T-test or
Mann-Whitney U test using SPSS 14 (SPSS Inc., Chi-
cago, IL). Gaussian distribution and equality of variances
were examined with Kolmogorov-Smirnov test and
Levene’s test, respectively. A T-test p-value of < 0.05
was considered statistically significant.
Results
Morphological characterization and proliferation of HDSC
and THESC upon in vitro differentiation
Decidual tissue attached to first trimester placentae,
purified HDSC and THESC were analysed with respect
to epithelial and stromal cell content using immuno-
fluorescence (Figure 1A). Sections of embedded, decid-
ual tissue showed vimentin and cytokeratin 7
expressions in stromal cells and residual glands, respec-
tively. Primary HDSC characterized at passage 3
Figure 1 Characterization of first trimester decidual tissue, primary HDSC and THESC using immunofluorescence and quantitative real-
time PCR. Preparation of tissue sections, isolation of primary HDSC, cultivation of THESC and quantitative real-time PCR were performed as
described in Materials and Methods. A) Immunofluorescence of decidual cells and tissue. First trimester decidual tissue isolated at 10th weeks of
pregnancy, primary human decidual stromal cells at passage 3, and THESC are depicted. Double immunofluorescence staining with antibodies
recognizing vimentin (red) and cytokeratin 7 (green) to detect stromal or epithelial cells, respectively, are shown. The respective counterstainings
of tissues and cultures with DAPI are depicted on the right hand side. Representative pictures were taken at a 100-fold (decidual tissue) and 200-
fold (cultivated cells) magnification, respectively. B) Quantitative real-time PCR measuring basal PRL and IGFBP1 mRNA expression in HDSC in a
passage-dependent manner. For normalization values at passage 1 were arbitrarily set at 1. Bars represent mean values ± S.D. of four different
experiments performed in duplicates. * indicates p < 0.05 compared to passage 1.
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contained mostly vimentin-positive cells with a small
numbers of cytokeratin 7-positive, contaminating epithe-
lial cells (0.83% ± 0.38 S.D., n = 6) whereas 100% of
THESC expressed vimentin. Since HDSC were derived
from early pregnancy decidua, cultures might already
express elevated levels of decidua-specific proteins.
Hence, to determine the optimal time point for in vitro
re-decidualization basal mRNA expression of decidual
marker genes was analysed in a passage-dependent man-
ner. Quantitative real-time PCR revealed residual PRL
and IGFBP1 mRNA levels in the early passages 1 and 2
which dropped upon further cultivation (Figure 1B).
Therefore, in vitro differentiation was routinely per-
formed with cultures at passage 3 to 5. Subsequently,
morphological changes and proliferation of in vitro
decidualizing cultures were assessed (Figure 2). Com-
pared to THESC showing a spindle-shaped, fibroblastoid
morphology, areas with cells displaying a cobblestone-
like morphology were observed in untreated HDSC (Fig-
ure 2A). Stimulation with cAMP strongly induced the
polygonal phenotype (Figure 2A) and provoked growth
arrest in both cell types (Figure 2B). Long-term treat-
ment with cAMP additionally reduced viability of HDSC
since compared to controls cell numbers significantly
decreased from day 6 onwards. In contrast, loss of cell
numbers could not be observed in cAMP-treated
THESC. Stimulation with E2P4 did not induce morpho-
logical changes in HDSC or THESC (Figure 2A). Prolif-
eration of both cell types was not affected upon
hormone treatment (Figure 2B).
Differentiation-dependent expression of progesterone
receptors in HDSC and THESC
Expression of PR was analysed in cAMP and/or E2P4
treated HDSC and THESC (Figure 3). Quantitative real-
time PCR revealed that cAMP significantly decreased
PR mRNA in HDSC at the different time points,
whereas E2P4 did not affect transcript levels (Figure
3A). Surprisingly, considerable, constitutive expression
of PR mRNA was detectable in THESC, but in contrast
to HDSC cAMP did not alter transcript levels (Figure
3A). Western blot analyses showed that HDSC also pro-
duced the PR proteins, PR-A (90 kD) and PR-B (118
kD), which were identified by using the PR-expressing
breast cancer cell line T47D [23] as a positive control
(Figure 3B). Both isoforms were suppressed in the
Figure 2 Morphological differentiation and proliferation of HDSC and THESC in the absence or presence of cAMP or E2P4. Cultivation,
in vitro decidualization and proliferation assays of HDSC and THESC were performed as described above. A) Morphological characteristics of
untreated and cAMP or E2P4-stimulated HDSC and THESC at day 6 of in vitro differentiation. Representative pictures at a 100-fold magnification
are shown. B) Proliferation of HDSC and THESC in the absence or presence of cAMP or E2P4. Cumulative cell numbers of each cultures system
(n = 4) were measured in duplicates at 1, 3, 6, 9, and 12 days of in vitro decidualization. * indicates p < 0.05 compared to negative control (n.c.)
of the same day; # indicates p < 0.05 compared to n.c. of day 0; n.s., not significant compared to n.c. of the same day.
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presence of cAMP (day 9 of differentiation), but did not
change upon E2P4 treatment. However, the PR antibody
specifically recognizing PR-A and PR-B in HDSC and
T47D cells failed to detect correct signals in cytoplasmic
and nuclear extracts of THESC in the absence or pre-
sence of cAMP and/or E2P4 (Figure 3C).
Expression of decidual marker genes in differentiating
HDSC and THESC
Next, expression of decidual marker genes was analysed
in untreated cultures and upon differentiation in the
presence of cAMP or E2P4 using quantitative real-time
PCR (Figure 4). PRL mRNA (Figure 4A) and IGFBP1
mRNA (Figure 4B) were strongly induced in HDSC
upon cAMP treatment. However, this response was
transient and highest levels of PRL and IGFBP1 tran-
scripts were detected at 3 days of cAMP stimulation.
Similarly, PRL mRNA (Figure 4A) and IGFBP1 mRNA
(Figure 4B) were induced in cAMP-treated THESC, but
expression of both genes remained at high levels during
differentiation. E2P4 treatment of HDSC provoked a
steady increase of transcript levels of PRL (Figure 4A)
and IGFBP1 (Figure 4B) which was significantly different
to controls from day 3 (PRL) and day 6 (IGFBP1)
onwards. In contrast neither PRL (Figure 4A) nor
IGFBP1 (Figure 4B) mRNA were induced in THESC in
the presence of E2P4. DKK1 has been recently described
as a progesterone-dependent but cAMP-independent
gene in decidualization [24]. Accordingly, E2P4
increased DKK1 mRNA expression in HDSC at day 3, 6,
9, and 12 of in vitro differentiation (Figure 4C). Com-
pared to the respective controls, its expression was also
induced upon cAMP treatment at 9 and 12 days of
HDSC differentiation (Figure 4C). In THESC, however,
DKK1 mRNA was not altered and suppressed in the
presence of E2P4 and cAMP, respectively (Figure 4C).
Figure 3 Expression analyses of PR in differentiating HDSC and THESC. Quantitative real-time PCR and Western blot analyses were
performed as described in Materials and Methods. Representative examples of Western blots are shown. A) PR mRNA expression at day 3, 6, 9,
and 12 of cAMP or E2P4 stimulation. For relative quantification of total PR mRNA expression, n.c. of day three was arbitrarily set at 1 (calibrator).
Bars indicate mean values ± SEM of seven and five different experiments performed in HDSC and THESC, respectively. PCR reactions were done
in duplicates. * indicates p < 0.05 compared to the n.c. of the same day; n.s., not significant. B) Western blot analyses showing PR protein
expression in total cellular extracts of dezidualizing HDSC. Specific signals detecting PR-A (90 kD) and PR-B (118 kD) in the absence or presence
of cAMP or E2P4 (day 9) are depicted. Total extracts prepared from T47D cells were used as a positive control. Marker bands are indicated on
the left. GAPDH was used as a loading control. C) Western blot analyses of cytoplasmic and nuclear extracts isolated from unstimulated and
differentiated THESC which had been treated with cAMP and/or E2P4 for 9 days. Specific signals detecting PR-A (90 kD) and PR-B (118 kD) in
T47D are depicted. Marker bands are indicated on the left and unspecific signals are indicated by stars. GAPDH and TopoIIb were used as
loading controls for cytoplasmic and nuclear extracts, respectively.
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Figure 4 Quantitative real-time PCR measuring mRNA expression of decidual marker genes in differentiating HDSC and THESC.
Cultures were incubated with cAMP or E2P4 for 3, 6, 9 and 12 days. Cells without stimuli were kept in parallel representing non-stimulated
controls (n.c.). RNA extraction and quantitative real-time PCR were performed as described in Methods. For relative quantification of mRNA
expression n.c. of day 3 was arbitrarily set at 1 (calibrator). Bars indicate mean values ± SEM of seven (HDSC) and five (THESC) different
experiments/PCR reactions performed in duplicates.* depicts p < 0.05 compared to the n.c. of the same day; n.s., not significant. A) PRL mRNA
expression. B) IGFBP1 mRNA expression. C) DKK1 mRNA expression.
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Moreover, the effects of a combined treatment with
cAMP and E2P4 were analysed in HDSC and THESC
(Figure 5). Real-time PCR of PRL (Figure 5A) and
IGFBP1 (Figure 5B) mRNAs revealed that, compared to
cAMP treatment alone, co-stimulation with cAMP and
E2P4 further enhanced mRNA expression in HDSC.
Increased mRNA expression of PRL (Figure 5A) and
IGFBP1 (Figure 5B) was also detectable in THESC upon
cAMP/E2P4 co-stimulation although the effects were
less pronounced than in HDSC.
Subsequently, PRL and IGFBP1 protein expression
were analysed in supernatants of HDSC and THESC
using ELISA and Western blotting, respectively (Figure
6). Similar to its mRNA levels, PRL protein was induced
upon cAMP or E2P4 stimulation of HDSC and expres-
sion further increased in the combined cAMP/E2P4
treatment (Figure 6A). PRL protein was also detectable
in cAMP-treated THESC (Figure 6A) but absent from
controls and E2P4-treated cells (not shown). Compared
to cAMP alone, its expression increased upon supple-
mentation of cAMP/E2P4. Soluble IGFBP1 protein also
closely mimicked its mRNA expression under the
different stimuli. Treatment of HDSC with cAMP pro-
voked transient expression of IGFBP1 with highest levels
at day 3, whereas in the presence of E2P4 the protein
was detectable at day 9 and further increased at day 12
(Figure 6B). In cAMP-treated THESC high IGFBP1
levels were observed between day 6 and day 12, whereas
the particular protein was absent from controls and
E2P4-treated cultures (Figure 6B).
Differentiation-dependent expression and localization of
FOXO1A in HDSC and THESC
Finally, expression and localization of FOXO1A, a criti-
cal, transcriptional regulator of the decidualization-asso-
ciated genes PRL and IGFBP-1 [12], were investigated
(Figure 7). Western blot analyses revealed that cAMP-
increased FOXO1A protein at all time points of differ-
entiation in HDSC and THESC, whereas E2P4 did not
change expression in both culture systems (Figure 7A).
Immunofluorescence of cells revealed nuclear localiza-
tion of FOXO1A upon cAMP stimulation (Figure 7B).
In unstimulated cultures, however, FOXO1A was diffu-
sely distributed within the cytoplasm (HDSC) or absent
Figure 5 Quantitative mRNA expression of decidual marker genes upon cAMP stimulation or combined treatment with cAMP and
E2P4 in differentiating HDSC and THESC. Cultures were incubated with E2P4 and/or cAMP for for 3, 6, 9 and 12 days and transcript levels
were analysed by real-time PCR. For relative quantification of mRNA expression, cAMP-treated samples were arbitrarily set at 100%. Bars indicate
mean values ± SEM of five and four different experiments performed in HESC and THESC, respectively. PCR reactions were done in duplicates. *
indicates p < 0.05 compared to the cAMP-stimulated sample of the same day; n.s., not significant. A) PRL mRNA expression. B) IGFBP1 mRNA
expression.
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(THESC). Quantification of fluorescent images indicated
an increase of FOXO1A-postive nuclei in both cell types
upon cAMP treatment, whereas E2P4 was not effective
(Figure 7C). Compared to cAMP stimulation, however,
the combined cAMP/E2P4 treatment decreased num-
bers of FOXO1A-postive nuclei in HDSC, but not in
THESC.
Discussion
Correct decidualization of the endometrium is indispen-
sable for proper implantation, fetal development and
successful progression of pregnancy. Hence, the underly-
ing molecular mechanisms are critical to our under-
standing of implantation defects associated with
infertility. Accordingly, in the recent years diverse in
vivo animal models have been developed involving
mouse and primate-systems [25,26]. In contrast to all
other species, however, human decidualization starts
spontaneously in the second half of the menstrual cycle
in response to the predominating ovarian progesterone
milieu. Therefore, adequate human in vitro models for
decidualization had to be established and still comprise
the basis to translate and verify results obtained from
animal models. Indeed, HESC obtained from endome-
trial biopsies of pre-menopausal women or from uterine
tissue after hysterectomy for benign gynaecological dis-
eases are widely used for cAMP and/or E2P4 or MPA-
induced in vitro differentiation [12,14]. However, avail-
ability of these samples might be limited, rising the need
for alternative systems.
Culture systems utilized for cAMP-dependent in vitro
decidualization
Therefore, efforts have been made to immortalize
human endometrial stromal cells to overcome the
restricted supply of primary HESC. Various immorta-
lized cell lines were established after lentiviral transduc-
tion of plasmids expressing either SV40 large T antigen
Figure 6 Differentiation-dependent protein expression of PRL and IGFBP1 in culture supernatants of HDSC and THESC. Cells were
stimulated in the absence or presence of cAMP and/or E2P4 for 3, 6, 9 and 12 days. Supernatants were collected and PRL and IGFBP1 protein
concentrations were measured by ELISA and Western blotting, respectively. Normalization of protein concentrations, ELISA, and
immunodetection of IGFBP1 on membranes were performed as mentioned in Materials and Methods. A) ELISA of PRL in HDSC and THESC. Data
represent mean values ± SEM of three experiments performed in duplicates. * indicates p < 0.05 compared to negative control (n.c.) of the
same day; n.s., not significant; # indicates p < 0.05 between cAMP-treated and cAMP/E2P4-stimulated cultures. PRL expression in controls and
E2P4-treated THESC were below the detection limit and therefore omitted from the graph. B) Western blot showing IGFBP1 (32 kD) expression
in HDSC and THESC. Marker bands (kD) are depicted on the left side. Representative examples are shown.
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[19,27,28] or telomerase [20,29,30]. In the presence of
cAMP these cell lines were shown to differentiate into a
cobblestone-like phenotype and to express marker genes
of decidualization such as IGFBP1, PRL and FOXO1A
[30]. The cAMP-dependent induction of PRL and
IGFBP1 in THESC analysed here confirms these pre-
vious observations. Hence, it can be concluded that the
cAMP-stimulated expression of markers genes might be
similar in the immortalized cells and primary HESC
suggesting suitability of cell lines for the particular dif-
ferentiation protocol.
The role of progesterone in in vitro decidualization
On the other hand, it was suggested that cAMP may not
be sufficient for maintenance of decidua-specific gene
expression in differentiating primary HESC but requires
Figure 7 FOXO1A protein expression during in vitro differentiation of HDSC and THESC. Cultures were incubated with cAMP and/or E2P4
for 3 and 9 days. Protein expression and localization of FOXO1A were determined by Western blotting and immunofluorescence, respectively, as
described in Materials and Methods. A) Western blot detecting FOXO1A (78 kD) in total cellular extracts. Marker bands (kD) are depicted on the
left side. GAPDH (37 kD) was used as a loading control. Representative examples are shown. B) Immunflourescence in untreated and cAMP-
stimulated HDCS and THESC. Representative pictures at a 200 fold magnification are shown. C) Quantification of FOXO1A-positive nuclei in cAMP
and/or E2P4-treated HDSC and THESC after immunofluorescence. Ratio (percentage) of positive nuclei were evaluated as described above. Bars
represent mean values ± SEM of three experiments. * indicates p < 0.05 compared to negative control (n.c.) of the same day; n.s., not significant;
# indicates p < 0.05 between cAMP-treated and cAMP/E2P4-stimulated cultures.
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the presence of progesterone [12]. Indeed, upon cAMP
treatment MPA-dependent induction of PRL has been
observed in HIESC-2 and St-TIb cultures [28,30] and
similar to primary HESC [12] the combined stimulation
was more efficient than cAMP treatment alone [30].
Moreover, MPA-induced expression of PRL and IGFBP1
in absence of cAMP has also been noticed in immorta-
lized cultures [20,29] suggesting a physiological, PR-
dependent response. However, as has been recently
pointed out MPA additionally interacts with glucocorti-
coid and androgen receptor [30], the latter being also
involved in decidualization [31]. Therefore, a response
to natural P4 rather than MPA and expression of PR as
occurs in primary HESC could be regarded as a hall-
mark of physiological decidualization and cell identity.
However, P4 responsiveness could not be detected in
two different immortalized endometrial stromal cell
lines [18,19]. Similarly, in THESC analysed here P4 did
not affect expression of DKK1, a progesterone-inducible
gene in HESC [24].
Expression of progesterone receptors in different model
systems of decidualization
Analyses of PR protein expression in the different immorta-
lized stromal cell lines such as THESC are either lacking
[20] or unclear due to the fact that appropriate positive
controls are missing [28,29]. Also, specificity of PR signals
of a particular cell line [28] was questioned since the PR
antibody used may show unspecific cross-reactivity [32].
The Western blot analyses performed here suggest that
PRs are absent from THESC providing an explanation for
the absence of P4 responsiveness. Although the PR anti-
body used in our study recognized two weak signals in
nuclear extracts of THESC, these bands showed different
molecular sizes than PR-A and PR-B produced in T47D
cells. Differently to the regulation of PR in HDSC and pri-
mary HESC [13] the signals were not suppressed upon
cAMP-induced differentiation. Therefore, we conclude that
the antibody unspecifically recognizes a nuclear protein in
THESC, particularly in the absence of PR protein. Interest-
ingly THESC, like the previously described St-TIb cells
[30], expressed considerable amounts of PR mRNA despite
the absence of PR proteins. Moreover, combined treatment
with cAMP and P4 of St-TIb [30] or of THESC provoked
elevated PRL mRNA and protein expression compared to
cAMP treatment alone. Considering the absence of nuclear
PR protein in both cell lines activation through P4 remains
elusive. Eventually, the effect might be explained by the
non-genomic actions of progesterone [33].
Human decidual stromal cells as an alternative model for
in vitro decidualization
An alternative for studying endometrial differentiation in
untransformed cultures has been suggested by using
isolated stromal cells from human term deciduas [34].
MPA- and cAMP-dependent induction of PRL and
IGFBP1 was observed in these cultures reflecting the
expression patterns observed in primary HESC. Further-
more, due to the strong similarities between HESC and
term decidual stromal cells it was suggested that both
cell types could be precursor decidual cells arising from
the same cell lineage [34]. In the present study primary
HDSC obtained from decidual tissue of early pregnancy
terminations have been evaluated as a model system for
in vitro differentiation. HDSC of early gestation develop
in a progesterone-rich environment promoting differen-
tiation. Indeed, at the time of isolation elevated basal
levels of PRL and IGFBP1 were noticed which upon in
vitro cultivation decreased in a passage-dependent man-
ner. After a minimum of 3 passages basal marker gene
expression of unstimulated cultures has sufficiently
decreased to commence re-decidualization. Indeed, dif-
ferentiated HESC also lose expression of decidua-speci-
fic genes upon withdrawal of stimuli [12]. Hence, we
conclude that the absence of cAMP and progesterone
promotes de-differentiation of HDSC, although the pre-
sence of residual progenitor cells in isolated cultures
cannot be excluded. Indeed, recent evidence suggested
that first trimester decidua contains spindle-shaped,
multipotent decidual stromal cells capable of differen-
tiating into diverse cell types including PRL-producing,
differentiated decidual cells [35].
Utilization of HDSC for cAMP or E2P4-induced in vitro
decidualization
Several lines of evidence presented here suggest that
HDSC could provide an alternative model system to
investigate cAMP and/or E2P4-dependent decidualiza-
tion. In accordance with the published literature using
HESC as model systems, HDSC had to be confluently
seeded for proper differentiation. Experiments with cells
at lower density revealed delayed induction of marker
gene expression when stimulated with cAMP or E2P4
(unpublished observation). Despite slow proliferation
due to contact inhibition, untreated cultures did not
spontaneously differentiate as verified by constant basal
levels of PRL and IGFBP1 mRNA during the entire sti-
mulation period. The presence of cAMP, provoking
changes in phenotype as well as growth arrest, resulted
in rapid induction of marker genes of decidualization, i.
e. PRL, IGFBP1 and FOXO1A. However, PRL and
IGFBP1 mRNA and protein were transiently expressed
and decreased at later time points of cAMP-stimulated
differentiation. Similar observations have been published
regarding PRL and IGFBP1 secretion in HESC
[12,13,36]. Hence, we assume that similar to HESC
cAMP treatment alone may not be sufficient for mainte-
nance of decidual marker gene expression in HDSC.
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In contrast to cAMP, administration of E2P4 did not
morphologically change HDSC but provoked a continu-
ous increase of PRL and IGFBP1 transcript and protein
levels. Indeed, it has been published that progestins also
induce a steady but modest increase of PRL and IGFBP1
mRNA expression in HESC [37]. Interestingly, E2P4-
and cAMP-induced PRL protein levels were similar at
day 9 of HDSC differentiation. In contrast, MPA-
induced PRL concentrations at day 6 and 8 of HESC dif-
ferentiation were shown to be approximately 1000 fold
less than cAMP-induced levels [12,13]. From these
observations we conclude that E2P4-dependent in vitro
decidualization could be more efficient in HDSC than in
HESC. This might be caused by higher endogenous
levels of cAMP in untreated HDSC or a steeper increase
in cAMP concentrations upon E2P4 treatment [15]. On
the other hand cAMP, known to induce apoptosis in
different culture systems [38,39], provoked loss of
HDSC after 6 days of incubation. Therefore, elevated
endogenous cAMP levels in HDSC as compared to
HESC could also provide an explanation for the higher
sensitivity of these cells to the cell-damaging effects of
exogenously added 8-Bromo-cAMP.
Combined cAMP and E2P4 treatment of HDSC
Compared to cAMP stimulation alone the combined
treatment with cAMP and E2P4 further increased PRL
and IGFBP1 mRNA expression and PRL protein levels in
HDSC. Elevated expression of these genes might suggest
that the combined treatment is necessary for complete
and sustained marker expression and differentiation of
HDSC as has been previously suggested for HESC
[12,13].
Along those lines, a natural progesterone response
could be detected in HDSC since P4 increased mRNA
levels of DKK1, which had been previously identified as
a progesterone-inducible gene [24], at early and late
time points of differentiation. In contrast to THESC,
protein expression of PR-A and PR-B was detectable in
isolated HDSC and both isoforms were downregulated
upon cAMP treatment. These results are in agreement
with studies performed in primary HESC triggered into
differentiation with the particular stimulus [13]. Further-
more, PR-A is the dominant isoform expressed in
HDSC mirroring the expression pattern observed both
in human endometrium during the secretory phase in
vivo as well as in isolated HESC in vitro [13,40,41].
Finally, compared to cAMP stimulation alone, combined
treatment with cAMP and E2P4 decreased nuclear
abundance of FOXO1A in HDSC indicating a hormone-
dependent effect. These data are agreement with pre-
vious observations in HESC [42] suggesting that proges-
terone could also promote survival of HDSC by
reducing cAMP-dependent apoptosis mediated through
FOXO1A. Genomic actions of nuclear PRs likely play a
role in cytoplasmic retention of FOXO1A since this
phenomenon could not be observed in PR-deficient
THESC.
Conclusion
Taken together, primary HDSC which were isolated
from first trimester decidual tissue and treated with
cAMP and/or E2P4 exhibit all features of correct decid-
ualization known from studies performed with HESC as
a model system. Even though single administration of
cAMP longer than 6 days could not be recommended
due to cell loss, short term differentiation proceeded
correctly and mirrored expression patterns in HESC.
E2P4 stimulation provoked continuous increases in mar-
ker gene expression suggesting that hormone-treatment
of HDSC provides a suitable in vitro system to study
human decidualization. Beside similar properties of
HESC and HDSC upon differentiation, the usage of first
trimester decidual tissues may eventually overcome the
problem of limited availability of endometrial samples
which can only be obtained when a benign gynaecologi-
cal disease has been diagnosed. Regarding THESC as a
model system cAMP-induced morphological transforma-
tion and marker gene expression can be achieved. How-
ever, P4-dependent differentiation may not be applicable
due to the lack of physiological progesterone-responsive-
ness and the absence of classical PRs.
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